Editorial: Phosphoinositides and their phosphatases: Linking electrical and chemical signals in biological processes by Susy C. Kohout & Carlos A. Villalba-Galea
EDITORIAL
published: 08 July 2015
doi: 10.3389/fphar.2015.00142
Frontiers in Pharmacology | www.frontiersin.org 1 July 2015 | Volume 6 | Article 142
Edited by:
Jean-Yves Le Guennec,
Université de Montpellier, France
Reviewed by:
Sébastien Roger,
University of Tours, France
*Correspondence:
Susy C. Kohout,
skohout@montana.edu;
Carlos A. Villalba-Galea,
cavillalbaga@vcu.edu
Specialty section:
This article was submitted to
Pharmacology of Ion Channels and
Channelopathies,
a section of the journal
Frontiers in Pharmacology
Received: 11 June 2015
Accepted: 26 June 2015
Published: 08 July 2015
Citation:
Kohout SC and Villalba-Galea CA
(2015) Editorial: Phosphoinositides
and their phosphatases: Linking
electrical and chemical signals in
biological processes.
Front. Pharmacol. 6:142.
doi: 10.3389/fphar.2015.00142
Editorial: Phosphoinositides and their
phosphatases: Linking electrical and
chemical signals in biological
processes
Susy C. Kohout 1* and Carlos A. Villalba-Galea 2*
1Department of Cell Biology and Neuroscience, Montana State University, Bozeman, MT, USA, 2Department of Physiology
and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
Keywords: voltage-sensing phosphatase, membrane potential, cell signaling, phosphatidylinositols, pten
The voltage-sensing phosphatase (VSP) has changed the way we think about both cellular electrical
activity and PIPs (phosphatidylinositol phosphates). Originally discovered in 1999 (Chen et al.,
1999), these proteins were not recognized as electrically-controlled enzymes until 2005 (Murata
et al., 2005). They constitute the first, and so far the only, example of an enzyme linking electrical
signals at the plasma membrane to the catalysis of PIPs (Murata et al., 2005), a ubiquitous family of
intracellular signaling molecules (Di Paolo and De Camilli, 2006; Balla, 2013). Before the discovery
of VSP, there were no known direct links between the two. Textbook examples would represent this
connection with arrows, alluding to indirect or “yet-to-be-defined” signaling pathways. Now we
know that VSP serves as a direct connection between the electrical nature of the cell and PIPs, lipid
second messengers that are critical for cell survival. However, many questions remain unanswered
regarding VSP and its electrical regulation of cellular processes.
With the discovery of VSP, the membrane potential must now be considered when studying PIP
regulators. PIPs are involved in almost all aspects of cell physiology from survival, proliferation,
and migration to pre-programed cell death (Di Paolo and De Camilli, 2006; Logothetis et al.,
2010; Koch and Holt, 2012; Balla, 2013). For example, PIP concentrations are actively polarized
in migrating cells with phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) on the leading edge
and phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) on the lagging edge (Leslie et al., 2008).
These gradients in the concentration of PIPs are necessary for activation of Rac and Rho leading
to cell motion. PIPs are also crucial for cell growth: PI(3,4,5)P3 activates the mTor cascade
leading to increased protein, membrane, and nucleic acid production (Dibble and Manning, 2013).
Many human diseases have been associated with altered homeostasis of PIPs, including cancer,
developmental disorders, and Alzheimer’s disease (Simpson and Parsons, 2001; McCrea and De
Camilli, 2009; Hakim et al., 2012). Though the physiological relevance of VSP is not yet defined, it
is still crucial to human health to understand how PIPs are regulated and that now includes VSP.
All cells have an asymmetric composition of ions across their plasma membrane, which,
combined with selective permeabilities for these ions, results in a difference in the electrical
potential across their plasmamembrane. This difference, called themembrane potential, constitutes
a form of cell signaling and a source of energy, both driving many biological processes. This
electrical potential difference powers neuronal excitability as well as more general processes like
proliferation, migration, and development (Levin, 2007; Sundelacruz et al., 2009; Yao et al., 2011).
Regulation by the membrane potential has long been the sole purview of ion channels and
transporters and that has influenced what questions are asked regarding the changing potential.
With our new knowledge of VSP, the changing membrane potential can directly signal the cell
by modulating mTor and cell growth pathways, leading to abnormal growth or the M-current in
sympathetic ganglion, leading to hyperexcitability.
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The articles in this Special Topic highlight several features
of VSP including its unique activation, its similarities to other
enzymes and its use as a versatile tool to study other proteins.
In the review article by Hobiger and Friedrich (2015, p. 20),
the authors compare the structural similarities and differences
between the broader family of protein tyrosine phosphatases
and one of its newest members, VSP. They suggest a catalytic
mechanism based on this comparison. Castle et al. (2015, p. 63)
investigate the activation mechanism of VSP by probing the C2
domain, the C-terminal domain of VSP that has been largely
unrecognized before the recent crystal structures showed a direct
contribution of the C2 residue Y522 into the active site. The work
byMavrantoni et al. (2015, p. 68) explores the techniques that are
used to test VSP and address some of their limitations including
the need for expensive electrophysiology equipment as well as the
limitations of using channels as functional reporters. They take
their methods and apply them to a chimera between the Ciona
intestinalis VSP and human PTEN and show how the chimera
allows for the investigation of PTEN using standard techniques
but with the advantage of regulated activation, voltage.
Beyond the molecular mechanism underlying VSP activity,
Mori et al. (2015, p. 22) review the use of VSP as a relatively
simple tool for manipulating PI(4,5)P2 concentrations in cells.
They have used VSP to study the PI(4,5)P2 regulation of transient
receptor potential canonical channels involved in receptor-
operated calcium currents. Along the same lines, Rjasanow
et al. (2015, p. 127) use VSP as a tool that gives them precise
control over the PI(4,5)P2 concentrations in the membrane.
These authors compared the relative PIP affinities between
several ion channels. They also point out an important limitation
that the channels must already have a known specificity for a
particular PIP because VSP does not destroy PIPs in contrast to
phospholipase C; instead, it generates multiple PIPs. All together,
these articles underscore the features of VSP and expand our
understanding of its function and utility.
Though VSP remains relatively unknown to many, this
nascent field has shown fast initial growth. The unique nature
of these enzymes has inspired many to investigate their
properties as well as take advantage of them. Many questions
remain unanswered regarding VSP such as how the voltage
sensor couples to the enzyme and whether the phosphatase
domain is brought to the membrane for activation or whether
a conformational change within the active site determines
activation. We look forward to the studies that will address these
and the many other questions that persist in this exciting field.
Acknowledgments
This work was supported by start-up funds from the Montana
State University Vice President for Research, Creativity and
Technology Transfer and NSF EPSCoR (EPS-1101342) to SK and
CTSA - KL2TR000057 to CV.
References
Balla, T. (2013). Phosphoinositides: tiny lipids with giant impact on cell regulation.
Physiol. Rev. 93, 1019–1137. doi: 10.1152/physrev.00028.2012
Castle, P. M., Zolman, K. D., and Kohout, S. C. (2015). Voltage-sensing
phosphatase modulation by a C2 domain. Front. Pharmacol. 6:63. doi:
10.3389/fphar.2015.00063
Chen, H., Rossier, C., Morris, M. A., Scott, H. S., Gos, A., Bairoch, A., et al. (1999).
A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine
phosphatase and maps to the pericentromeric region of human chromosomes
21 and 13, and to chromosomes 15, 22, and Y. Hum. Genet. 105, 399–409. doi:
10.1007/s004390051122
Dibble, C. C., and Manning, B. D. (2013). Signal integration by mTORC1
coordinates nutrient input with biosynthetic output.Nat. Cell Biol. 15, 555–564.
doi: 10.1038/ncb2763
Di Paolo, G., and De Camilli, P. (2006). Phosphoinositides in cell regulation and
membrane dynamics. Nature 443, 651–657. doi: 10.1038/nature05185
Hakim, S., Bertucci, M. C., Conduit, S. E., Vuong, D. L., and Mitchell, C. A. (2012).
Inositol polyphosphate phosphatases in human disease. Curr. Top. Microbiol.
Immunol. 362, 247–314. doi: 10.1007/978-94-007-5025-8_12
Hobiger, K., and Friedrich, T. (2015). Voltage sensitive phosphatases: emerging
kinship to protein tyrosine phosphatases from structure-function research.
Front. Pharmacol. 6:20. doi: 10.3389/fphar.2015.00020
Koch, M., and Holt, M. (2012). Coupling exo- and endocytosis: an essential
role for PIP2 at the synapse. Biochim. Biophys. Acta 1821, 1114–1132. doi:
10.1016/j.bbalip.2012.02.008
Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L., and Downes, C. P. (2008).
Understanding PTEN regulation: PIP2, polarity and protein stability.Oncogene
27, 5464–5476. doi: 10.1038/onc.2008.243
Levin, M. (2007). Large-scale biophysics: ion flows and regeneration. Trends Cell
Biol. 17, 261–270. doi: 10.1016/j.tcb.2007.04.007
Logothetis, D. E., Petrou, V. I., Adney, S. K., and Mahajan, R. (2010).
Channelopathies linked to plasmamembrane phosphoinositides. Pflugers Arch.
460, 321–341. doi: 10.1007/s00424-010-0828-y
Mavrantoni, A., Thallmair, V., Leitner, M. G., Schreiber, D. N., Oliver, D., and
Halaszovich, C. R. (2015). A method to control phosphoinositides and to
analyze PTEN function in living cells using voltage sensitive phosphatases.
Front. Pharmacol. 6:68. doi: 10.3389/fphar.2015.00068
McCrea, H. J., and De Camilli, P. (2009). Mutations in phosphoinositide
metabolizing enzymes and human disease. Physiology 24, 8–16. doi:
10.1152/physiol.00035.2008
Mori, M. X., Itsuki, K., Hase, H., Sawamura, S., Kurokawa, T., Mori, Y., et al.
(2015). Dynamics of receptor-operated Ca2+ currents through TRPC channels
controlled via the PI(4,5)P2-PLC signaling pathway. Front. Pharmacol. 6:22.
doi: 10.3389/fphar.2015.00022
Murata, Y., Iwasaki, H., Sasaki, M., Inaba, K., and Okamura, Y. (2005).
Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor.
Nature 435, 1239–1243. doi: 10.1038/nature03650
Rjasanow, A., Leitner, M. G., Thallmair, V., Halaszovich, C. R., and Oliver,
D. (2015). Ion channel regulation by phosphoinositides analyzed with
VSPs—PI(4,5)P2 affinity, phosphoinositide selectivity, and PI(4,5)P2
pool accessibility. Front. Pharmacol. 6:127. doi: 10.3389/fphar.2015.
00127
Simpson, L., and Parsons, R. (2001). PTEN: life as a tumor suppressor. Exp. Cell
Res. 264, 29–41. doi: 10.1006/excr.2000.5130
Sundelacruz, S., Levin, M., and Kaplan, D. L. (2009). Role of membrane potential
in the regulation of cell proliferation and differentiation. Stem Cell Rev. 5,
231–246. doi: 10.1007/s12015-009-9080-2
Yao, L., Pandit, A., Yao, S., and McCaig, C. D. (2011). Electric field-guided neuron
migration: a novel approach in neurogenesis. Tissue Eng. Part B Rev. 17,
143–153. doi: 10.1089/ten.teb.2010.0561
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Kohout and Villalba-Galea. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Pharmacology | www.frontiersin.org 2 July 2015 | Volume 6 | Article 142
